AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

AACC COVID 19 Testing Survey

Since COVID-19 reached the U.S., AACC’s members—who are lab experts on the frontlines of testing for the virus—have reported that persistent shortages of essential supplies are hindering labs from reaching their full testing capacity for COVID-19. In response to these concerns, AACC is conducting an ongoing study to determine the full extent of these supply shortages and how they are changing as the pandemic progresses, in the hopes that this data can help inform a potential solution.

For the study, AACC has so far surveyed clinical labs worldwide about this issue during four different time periods: May 1-24, June 1-5, June 24-July 6, and August 3-18. The results show a troubling trend—namely, that more than half of all responding labs still do not have the supplies they need to run COVID-19 tests.

Additionally, the August iteration of the survey found that, for U.S. labs:

  • 67% of all responding labs are having issues getting both reagents and test kits for COVID-19 testing, which is the highest this figure has been since AACC began surveying labs in May.
  • 28% of responding labs offering COVID-19 testing expect to be unable to process all requested COVID-19 tests within the week after they were surveyed because of supply issues and challenges. This is up from 25% of labs facing this issue in late June/early July and 21% of labs struggling with this in May.
  • 32% of responding labs are now having trouble getting supplies for non-COVID-19 tests, which is up from only 12% of labs having this issue in late June/early July.
  • After supply shortages, staffing is the 2nd biggest challenge for labs performing COVID-19 testing, with 58% of responding labs reporting issues with this.

Explore the full survey results


AACC is continuing to collect data on this issue and will regularly update the information on this page to reflect the evolving nature of the COVID-19 crisis, as well as AACC’s latest efforts to use this data to shape the direction of public policy.

July Survey Results

On July 28, AACC presented the following findings to the White House Coronavirus Task Force in a letter that called on the federal government to take a more active role in alleviating COVID-19 testing supply shortages:

Figure 1 Percentage of Respondent Laboratories Unable to Obtain COVID-19 Testing Supplies

Figure 1: As of July 6, 46% of all responding labs were still unable to obtain COVID-19 testing supplies (a number that has gone up to 52% of responding labs in August). As shown in the figure above, 69 labs answered this question during the May 1-24 period; 31 labs answered from June 1-5; and 50 labs answered from June 24-July 6.

Figure 2. Which Supplies are Respondent Labs Unable to Procure (June 24-July 6)?

Figure 2: In July, COVID-19 test kits and reagents (the chemicals used to perform these tests) were the supplies that labs were having the most difficulty procuring—a problem that has only worsened in August. As shown in the figure above, 24 labs responded to this question during the June 24-July 6 period.

Participate in the Survey

If your laboratory would like to participate in AACC’s future COVID-19 testing surveys, please contact Caitlin Ondracek, PhD, AACC Associate Director of Science and Practice Programs, at condracek@aacc.org.

You are also welcome to send any feedback on the survey to Dr. Ondracek.

More About the Survey

AACC has partnered on this project with Edgeworth Analytics, a leading data analytics firm of PhD economists who use proven methods of gathering, structuring, and analyzing data to make results accessible and maximize insights.

Participants in the survey include laboratory directors among AACC’s membership as well as participants in AACC's COVID-19 Testing Directory, and they represent both hospital/public health labs and commercial/reference labs.

In the U.S., during the May 1-24 period, 100 labs responded to the full survey; during the June 1-5 period, 33 labs responded; during the June 24-July 6 period, 53 labs responded; and during the August 3-18 period, 67 labs responded.

Collected laboratory information is not associated with specific contact information and participants were allowed to opt out at any point.